Skip to content

Characterization of Opposition to Organ Donation at Strasbourg University Hospital in 2024-2025

Characterization of Opposition to Organ Donation at Strasbourg University Hospital in 2024-2025

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07345975
Acronym
OPPO-PMO
Enrollment
100
Registered
2026-01-16
Start date
2025-10-14
Completion date
2027-02-14
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Organ Donation

Keywords

Organ Donation, Organ transplant

Brief summary

In 2024, 29,000 people are waiting for organ transplants in France, and only 6,034 transplants were performed during the year. 852 people died while waiting for a transplant. The gap between the number of available transplants and the number of patients waiting for transplants has been widening since the 1990s; there is talk of a shortage of transplants. There is therefore an urgent need to find more transplants and mobilize the entire population to this end. French law supports presumed consent, meaning that we are all donors unless we have expressed otherwise during our lifetime. In fact, 80% of French people say they are in favor of organ donation after their death, but few discuss it with their loved ones. When families are approached about multi-organ removal to gather any opposition from the deceased, the refusal rate is 37% (compared to an expected 20%). It is difficult to determine whether this opposition truly comes from the deceased themselves, their loved ones, uncertainty, or the situation. As this is the leading cause of non-donation, it is essential to better characterize this opposition in order to reduce it and allow for more organ donation and, ultimately, transplantation.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who are brain dead and/or eligible for a Maastricht 3 protocol (discontinuation of active treatment with death due to circulatory arrest in intensive care) * Hospitalized in the intensive care unit of the Strasbourg University Hospital or transferable to the Strasbourg University Hospital for multi-organ removal (anticipated approach) * Existence of relatives with whom discussion is possible * Presence of organ procurement coordination at the initial donation interview

Exclusion criteria

* Absence of relatives of the deceased (no interview with them) * Absence of organ procurement coordination during the initial discussion with relatives regarding organ and tissue procurement

Design outcomes

Primary

MeasureTime frameDescription
Distribution of positions regarding organ donation (certain, uncertain, unknown)Up to 12 monthsDistribution of positions regarding organ donation (certain, uncertain, unknown): For illustration purposes: * Certain position: ≈ 65% * Favorable: ≈ 55% * Opposed: ≈ 10% * Uncertain position: ≈ 25% * Unknown/unexpressed position: ≈ 10%

Countries

France

Contacts

Primary ContactCharlotte POUSSARDIN, MD
charlotte.poussardin@chru-strasbourg.fr33 3.69.55.16.21

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026